News
FDA approves first drug for myelofibrosis with thrombocytopenia
Treatment option is the first for patients who have myelofibrosis with low platelet counts.
News
FDA approves new CAR T-cell treatment for multiple myeloma
Study results show that this treatment for refractory/relapsed multiple myeloma can provide deep, durable responses and long treatment-free...
News
FDA approves first drug for rare inherited anemia
First-ever drug for hemolytic anemia has been approved by the Food and Drug Administration.
News
FDA approves first-ever drug for cold agglutinin disease
The first drug to treat a rare anemia has been given the green light by the FDA.
News
New approval in early breast cancer: First advance in 20 years
Abemaciclib had already been approved for use in the treatment of HR+, HER2– advanced or metastatic breast cancer.
News
Accelerated approval now full for pembro in bladder cancer
Pembrolizumab is for first-line locally advanced or metastatic urothelial carcinoma for patients not eligible for platinum-containing chemotherapy...
News
Stop using Neutrogena and Aveeno spray sunscreen, J&J warns
Consumers should stop using these products and throw them away, the company said.
News
First CAR T-cell therapy for multiple myeloma: Abecma
“The results of this trial represent a true turning point in the treatment of this disease.”
News
FDA approves first agent for PSMA-PET imaging in prostate cancer
The diagnostic agent Gallium 68 PSMA-11 has been approved for institutional use only.
News
FDA approves belantamab in relapsed/refractory multiple myeloma
The first-in-class drug belantamab mafodotin (Blenrep) has been approved in the United States for use in relapsed and refractory multiple myeloma...